Inovio Pharmaceuticals News - INO

Company Name	Stock Ticker Symbol	Market	Type
Inovio Pharmaceuticals Inc New	INO	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	-0.87	-7.86%	10.20	16:17:26

Open Price	Low Price	High Price	Close Price	Prev Close
11.00	10.1201	11.00	10.20	11.07

more quote information »

Recent News

Date	Time	Source	Heading
4/15/2024	18:39	PRNUS	INOVIO Announces Pricing of Approximately $36 Million..
3/26/2024	18:28	PRNUS	INOVIO to Participate in The Citizens JMP Novel Therapeutics..
3/06/2024	16:05	PRNUS	INOVIO Reports Fourth Quarter and Full Year 2023 Financial..
3/06/2024	07:00	PRNUS	Geneos Therapeutics to Present New Clinical Data on..
3/06/2024	06:02	IHMARKETNEWS	U.S. Stock Futures Gain Ahead of Economic Insights; Oil..
2/21/2024	08:00	PRNUS	INOVIO to Report Fourth Quarter and Year-End 2023 Financial..
2/07/2024	11:46	PRNUS	INOVIO to Present at the Oppenheimer 34th Annual Healthcare..
2/02/2024	08:00	PRNUS	INOVIO Reports Inducement Grant Under Inducement Plan
2/01/2024	00:15	EDGAR2	Form EFFECT - Notice of Effectiveness
1/26/2024	16:01	EDGAR2	Form S-3/A - Registration statement under Securities Act of..
1/25/2024	16:02	EDGAR2	Form 8-K - Current report
1/23/2024	08:00	PRNUS	INOVIO Announces Effective Date of 1-for-12 Reverse Stock..
1/22/2024	08:00	PRNUS	INOVIO to Participate in Virtual Fireside Chat on the..
1/12/2024	17:27	EDGAR2	Form 8-K - Current report
1/04/2024	08:00	PRNUS	INOVIO and Coherus Announce Clinical Collaboration to..
1/03/2024	08:00	PRNUS	INOVIO Plans to Submit a BLA for INO-3107 as a Potential..
11/28/2023	16:05	EDGAR2	Form DEF 14A - Other definitive proxy statements
11/17/2023	16:00	EDGAR2	Form PRE 14A - Other preliminary proxy statements
11/09/2023	16:35	EDGAR2	Form S-3 - Registration statement under Securities Act of..
11/09/2023	16:15	EDGAR2	Form 8-K - Current report
11/09/2023	16:05	PRNUS	INOVIO Reports Third Quarter 2023 Financial Results and..
11/09/2023	16:00	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/02/2023	16:01	EDGAR2	Form 8-K - Current report
11/01/2023	08:00	PRNUS	INOVIO Reports Inducement Grants Under Inducement Plan
10/26/2023	08:00	PRNUS	INOVIO to Report Third Quarter 2023 Financial Results on..
10/10/2023	16:00	EDGAR2	Form 8-K - Current report
10/10/2023	10:51	DJN	Inovio Shares Rise 8% After FDA Feedback for INO-3107
10/10/2023	08:00	PRNUS	INOVIO Receives FDA Feedback that Data from Completed Phase..
9/27/2023	19:39	PRNUS	Geneos Therapeutics Closes its Series A3 Financing With..
9/07/2023	08:00	PRNUS	INOVIO Announces U.S. FDA Breakthrough Therapy Designation..
8/29/2023	08:00	PRNUS	INOVIO to Present at the H.C. Wainwright 25th Annual Global..
8/09/2023	16:23	EDGAR2	Form 8-K - Current report
8/09/2023	16:05	PRNUS	INOVIO Announces Second Quarter 2023 Financial Results and..
8/09/2023	16:00	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/04/2023	08:00	PRNUS	INOVIO Reports Inducement Grants Under Inducement Plan
7/31/2023	21:43	EDGAR2	Form 8-K - Current report
7/26/2023	09:32	PRNUS	INOVIO to Report Second Quarter 2023 Financial Results on..
7/07/2023	16:35	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
7/03/2023	17:12	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
6/23/2023	16:10	GLOBE	INOVIO Announces Notice of Pendency and Proposed Settlement..
6/01/2023	08:00	PRNUS	INOVIO Reports Inducement Grants Under Inducement Plan
5/25/2023	08:00	PRNUS	INOVIO to Present at the 2023 Jefferies Healthcare..
5/23/2023	16:13	PRNUS	INOVIO Announces Orphan Drug Designation for INO-3107 for..
5/10/2023	16:05	PRNUS	INOVIO Reports First Quarter 2023 Financial Results and..
5/08/2023	08:00	PRNUS	New Data from Phase 1/2 Trial of INO-3107 for the Treatment..
5/05/2023	08:00	PRNUS	INOVIO to Present at the 2023 RBC Capital Markets Global..
4/28/2023	08:00	PRNUS	INOVIO to Report First Quarter 2023 Financial Results on May..
4/27/2023	08:00	PRNUS	INOVIO Announces Acceptance of Abstract for Oral..
4/26/2023	08:00	PRNUS	European Committee for Orphan Medicinal Products Provides..